Cargando…
Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation
Atrial fibrillation (AF) is associated with an increased risk of stroke, which can be prevented by the use of oral anticoagulation. Although non-vitamin K antagonist oral anticoagulants (NOACs) have become the first choice for stroke prevention in the majority of patients with non-valvular AF, adher...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850710/ https://www.ncbi.nlm.nih.gov/pubmed/35185408 http://dx.doi.org/10.1093/eurheartj/suab152 |
_version_ | 1784652659606683648 |
---|---|
author | Farinha, José Maria Jones, Ian D Lip, Gregory Y H |
author_facet | Farinha, José Maria Jones, Ian D Lip, Gregory Y H |
author_sort | Farinha, José Maria |
collection | PubMed |
description | Atrial fibrillation (AF) is associated with an increased risk of stroke, which can be prevented by the use of oral anticoagulation. Although non-vitamin K antagonist oral anticoagulants (NOACs) have become the first choice for stroke prevention in the majority of patients with non-valvular AF, adherence and persistence to these medications remain suboptimal, which may translate into poor health outcomes and increased healthcare costs. Factors influencing adherence and persistence have been suggested to be patient-related, physician-related, and healthcare system-related. In this review, we discuss factors influencing patient adherence and persistence to NOACs and possible problem solving strategies, especially involving an integrated care management, aiming for the improvement in patient outcomes and treatment satisfaction. |
format | Online Article Text |
id | pubmed-8850710 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-88507102022-02-17 Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation Farinha, José Maria Jones, Ian D Lip, Gregory Y H Eur Heart J Suppl Supplement Papers Atrial fibrillation (AF) is associated with an increased risk of stroke, which can be prevented by the use of oral anticoagulation. Although non-vitamin K antagonist oral anticoagulants (NOACs) have become the first choice for stroke prevention in the majority of patients with non-valvular AF, adherence and persistence to these medications remain suboptimal, which may translate into poor health outcomes and increased healthcare costs. Factors influencing adherence and persistence have been suggested to be patient-related, physician-related, and healthcare system-related. In this review, we discuss factors influencing patient adherence and persistence to NOACs and possible problem solving strategies, especially involving an integrated care management, aiming for the improvement in patient outcomes and treatment satisfaction. Oxford University Press 2022-02-14 /pmc/articles/PMC8850710/ /pubmed/35185408 http://dx.doi.org/10.1093/eurheartj/suab152 Text en Published on behalf of the European Society of Cardiology. © The Author(s) 2022. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Supplement Papers Farinha, José Maria Jones, Ian D Lip, Gregory Y H Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation |
title | Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation |
title_full | Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation |
title_fullStr | Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation |
title_full_unstemmed | Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation |
title_short | Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation |
title_sort | optimizing adherence and persistence to non-vitamin k antagonist oral anticoagulant therapy in atrial fibrillation |
topic | Supplement Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850710/ https://www.ncbi.nlm.nih.gov/pubmed/35185408 http://dx.doi.org/10.1093/eurheartj/suab152 |
work_keys_str_mv | AT farinhajosemaria optimizingadherenceandpersistencetononvitaminkantagonistoralanticoagulanttherapyinatrialfibrillation AT jonesiand optimizingadherenceandpersistencetononvitaminkantagonistoralanticoagulanttherapyinatrialfibrillation AT lipgregoryyh optimizingadherenceandpersistencetononvitaminkantagonistoralanticoagulanttherapyinatrialfibrillation |